Vancomycin and Cutaneous vasculitis - a phase IV clinical study of FDA data

Summary:

Cutaneous vasculitis is reported as a side effect among people who take Vancomycin (vancomycin), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Pantoprazole, and have Osteomyelitis.

The phase IV clinical study analyzes which people have Cutaneous vasculitis when taking Vancomycin. It is created by eHealthMe based on reports of 17,160 people who have side effects when taking Vancomycin from the FDA, and is updated regularly.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.

What is Cutaneous vasculitis?

Cutaneous vasculitis (an inflammatory process affecting the vessel wall that leads to its damage) is found to be associated with 245 drugs and 344 conditions by eHealthMe. Check the latest studies of Cutaneous vasculitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

17,160 people reported to have side effects when taking Vancomycin.
Among them, 47 people (0.27%) have Cutaneous vasculitis.

Could Vancomycin cause Cutaneous vasculitis?

Among these 47 people:

How long have people been on Vancomycin when they have Cutaneous vasculitis? *

What is the gender of people who have Cutaneous vasculitis when taking Vancomycin? *

female: 32.61 %
male: 67.39 %

What is the age of people who have Cutaneous vasculitis when taking Vancomycin? *

What are other drugs people take besides Vancomycin? *

Pantoprazole: 8 people, 17.02%
Folic Acid: 4 people, 8.51%
Cefazolin: 4 people, 8.51%
Meropenem: 4 people, 8.51%
Aspirin: 3 people, 6.38%
Furosemide: 3 people, 6.38%
Dipyrone: 3 people, 6.38%
Gabapentin: 3 people, 6.38%
Nph Insulin: 3 people, 6.38%
Piperacillin And Tazobactam: 3 people, 6.38%

What are other side effects people have besides Cutaneous vasculitis? *

Henoch-Schonlein Purpura (inflammation of the blood vessels in the skin and other body organs): 6 people, 12.77%
Eosinophilia (eosinophil count in the peripheral blood exceeds): 6 people, 12.77%
Acute Kidney Failure: 4 people, 8.51%
Palpable Purpura (purple or brownish-red spots on the skin or mucous): 4 people, 8.51%
Acute Respiratory Failure: 3 people, 6.38%
Cardiac Arrest: 3 people, 6.38%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 3 people, 6.38%
Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 3 people, 6.38%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 3 people, 6.38%
Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli): 2 people, 4.26%

What are the existing conditions these people have? *

Osteomyelitis (infection of bone): 20 people, 42.55%
Fungal Infection: 5 people, 10.64%
Upper Aerodigestive Tract Infection: 5 people, 10.64%
Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 8.51%
High Blood Pressure: 3 people, 6.38%
Wound Dehiscence (a surgical incision reopens either internally or externally): 3 people, 6.38%
Escherichia Infection (bacterial infection by escherichia coli): 2 people, 4.26%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 1 person, 2.13%
Klebsiella Infection: 1 person, 2.13%
Pneumonia: 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Vancomycin and have Cutaneous vasculitis?

- Check whether Cutaneous vasculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vancomycin:

Vancomycin (17,165 reports)

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cutaneous vasculitis:

Cutaneous vasculitis (245 drugs)

Browse all the conditions that are associated with Cutaneous vasculitis:

Cutaneous vasculitis (344 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vancomycin (the active ingredients of Vancomycin) and Vancomycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.